CA2753121A1 - Compositions and methods to prevent and/or treat cancer with pa-card - Google Patents
Compositions and methods to prevent and/or treat cancer with pa-card Download PDFInfo
- Publication number
- CA2753121A1 CA2753121A1 CA2753121A CA2753121A CA2753121A1 CA 2753121 A1 CA2753121 A1 CA 2753121A1 CA 2753121 A CA2753121 A CA 2753121A CA 2753121 A CA2753121 A CA 2753121A CA 2753121 A1 CA2753121 A1 CA 2753121A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- laz
- peptide
- card
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15423609P | 2009-02-20 | 2009-02-20 | |
US61/154,236 | 2009-02-20 | ||
US17943509P | 2009-05-19 | 2009-05-19 | |
US61/179,435 | 2009-05-19 | ||
PCT/US2010/024904 WO2010096754A1 (en) | 2009-02-20 | 2010-02-22 | Compositions and methods to prevent and/or treat cancer with pa -card |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2753121A1 true CA2753121A1 (en) | 2010-08-26 |
Family
ID=42634238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2753121A Abandoned CA2753121A1 (en) | 2009-02-20 | 2010-02-22 | Compositions and methods to prevent and/or treat cancer with pa-card |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2398486A4 (zh) |
JP (1) | JP2012518417A (zh) |
KR (1) | KR20120000062A (zh) |
CN (1) | CN102387809A (zh) |
AU (1) | AU2010215858A1 (zh) |
CA (1) | CA2753121A1 (zh) |
IL (1) | IL214757A0 (zh) |
SG (1) | SG174136A1 (zh) |
WO (1) | WO2010096754A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8338368B2 (en) | 2005-11-07 | 2012-12-25 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting physiological solubility and stability |
WO2014049604A2 (en) * | 2012-09-05 | 2014-04-03 | Amrita Therapeutics Limited | A novel biomedical device for cancer therapy |
KR101838160B1 (ko) * | 2013-02-05 | 2018-03-13 | 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 | 항-마이코플라즈마 에스피피. 아단위 백신 |
CN103554187B (zh) * | 2013-09-18 | 2016-03-30 | 中国科学技术大学 | 铂类配合物、由该铂类化合物制得的蛋白质复合物及其制备方法 |
USD844857S1 (en) * | 2017-10-05 | 2019-04-02 | Western Interlock, Inc. | Retaining wall corner block |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE452185T1 (de) * | 1999-01-26 | 2010-01-15 | Univ London | Dimethylarginin-dimethylaminohydrolasen |
US20020164703A1 (en) * | 2000-12-21 | 2002-11-07 | Krzysztof Pawlowski | Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
US7691383B2 (en) * | 2004-10-07 | 2010-04-06 | The Board Of Trustees Of The University Of Illinois | Cupredoxin derived transport agents and methods of use thereof |
GB0211295D0 (en) * | 2002-05-16 | 2002-06-26 | Univ London | Treatment of pain |
-
2010
- 2010-02-22 JP JP2011551270A patent/JP2012518417A/ja active Pending
- 2010-02-22 AU AU2010215858A patent/AU2010215858A1/en not_active Abandoned
- 2010-02-22 EP EP10744428A patent/EP2398486A4/en not_active Withdrawn
- 2010-02-22 CN CN2010800160848A patent/CN102387809A/zh active Pending
- 2010-02-22 CA CA2753121A patent/CA2753121A1/en not_active Abandoned
- 2010-02-22 SG SG2011059458A patent/SG174136A1/en unknown
- 2010-02-22 KR KR1020117021883A patent/KR20120000062A/ko not_active Application Discontinuation
- 2010-02-22 WO PCT/US2010/024904 patent/WO2010096754A1/en active Application Filing
-
2011
- 2011-08-18 IL IL214757A patent/IL214757A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010096754A8 (en) | 2011-04-28 |
JP2012518417A (ja) | 2012-08-16 |
KR20120000062A (ko) | 2012-01-03 |
IL214757A0 (en) | 2011-11-30 |
EP2398486A1 (en) | 2011-12-28 |
EP2398486A4 (en) | 2012-11-21 |
WO2010096754A1 (en) | 2010-08-26 |
AU2010215858A1 (en) | 2011-09-22 |
CN102387809A (zh) | 2012-03-21 |
SG174136A1 (en) | 2011-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8545812B2 (en) | Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof | |
US10889621B2 (en) | Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins | |
KR20090095626A (ko) | 쿠프레독신과 CpG 리치 DNA를 이용한 조성물 및 암 치료 방법 | |
US10058585B2 (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof | |
CA2753121A1 (en) | Compositions and methods to prevent and/or treat cancer with pa-card | |
US9968685B2 (en) | Methods to treat cancer with cupredoxins | |
KR20110128878A (ko) | 큐프레독신 유래 펩티드의 변형 및 이의 사용방법 | |
US10072049B2 (en) | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof | |
US20100278937A1 (en) | Compositions and methods to prevent and/or treat cancer with pa-card | |
US10675326B2 (en) | Compositions comprising cupredoxins for treating cancer | |
CN101490270A (zh) | 用于穿越血脑屏障并进入脑部癌细胞的转运剂及其使用方法 | |
JP2009502797A (ja) | 血管形成をキュプレドキシンで制御するための組成物および方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20140224 |